Baird Medical Investment Holdings Limited
NASDAQ:BDMD · NASDAQ Capital Market
-$0.09 today
Vol 0.08M · Avg 0.37M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:BDMD · Revenue to Net Income
Key Ratios
Analysis
$59.6M of revenue converted into -$14.8M of net income for the selected period. Gross margin is 85.7% and net margin is -46.1%, showing how much revenue survives after costs and taxes. EPS is $-0.92, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.5M -39.2% | $37.0M +17.7% | $31.5M -10.4% | $35.1M +26.6% | $27.7M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $3.7M -16.7% | $4.4M +3.7% | $4.2M -40.1% | $7.1M +55.2% | $4.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $18.9M -42.2% | $32.7M +19.9% | $27.2M -2.9% | $28.0M +21.0% | $23.2M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 83.8% -4.4pp | 88.2% +1.6pp | 86.6% +6.7pp | 79.9% -3.7pp | 83.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $20.1M +226.0% | $6.2M +44.4% | $4.3M +10.8% | $3.9M +271.1% | $1.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $24.4M +144.7% | $10.0M -10.2% | $11.1M +5.2% | $10.5M +3.2% | $10.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $44.4M +156.2% | $17.3M +12.8% | $15.4M +18.0% | $13.0M +33.5% | $9.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $1.1M -26.8% | $1.5M +48.6% | $1.0M -31.0% | $1.5M +5.0% | $1.4M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$24.5M -251.7% | $16.2M +25.6% | $12.9M -21.0% | $16.3M +15.1% | $14.2M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -108.9% -152.5pp | 43.7% +2.7pp | 40.9% -5.5pp | 46.4% -4.6pp | 51.1% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$25.5M -266.7% | $15.3M +29.1% | $11.9M -13.0% | $13.6M +14.4% | $11.9M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -113.3% -154.7pp | 41.4% +3.6pp | 37.7% -1.1pp | 38.8% -4.1pp | 43.0% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 -100.0% | $393 | $0 -100.0% | $8.6K +267.7% | $2.3K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $737.4K +27.8% | $576.8K +102.9% | $284.3K -5.0% | $299.3K +94.4% | $153.9K | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$837.6K +31.8% | -$1.2M -346.8% | $497.5K -44.1% | $890.2K +29.3% | $688.3K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$26.4M -287.2% | $14.1M +14.0% | $12.4M -14.9% | $14.5M +15.2% | $12.6M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -117.0% -155.1pp | 38.0% -1.3pp | 39.3% -2.1pp | 41.4% -4.1pp | 45.5% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $1.2M -21.7% | $1.5M -12.5% | $1.7M -2.6% | $1.7M -27.9% | $2.4M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$27.3M -319.0% | $12.5M +18.1% | $10.5M -16.1% | $12.6M +7.6% | $11.7M | $4.9B | $4.8B | $4.7B |
| Net Margin | -121.0% -154.7pp | 33.6% +0.1pp | 33.5% -2.3pp | 35.8% -6.3pp | 42.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$1 -300.0% | $0 +19.5% | $0 +1789.4% | $0 +189.7% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$1 -300.0% | $0 +19.5% | $0 +1789.4% | $0 +189.7% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $27.8M +8.8% | $25.6M +237.0% | $7.6M +20.6% | $6.3M -12.5% | $7.2M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $27.8M +8.4% | $25.6M +237.9% | $7.6M +5.5% | $7.2M +0.0% | $7.2M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Biodesix, Inc.
NASDAQ:BDSX
$122.59M
electroCore, Inc.
NASDAQ:ECOR
$85.03M
OnKure Therapeutics, Inc.
NASDAQ:OKUR
$57.43M
FibroGen, Inc.
FGEN
$36.69M
NeuroOne Medical Technologies Corporation
NMTC
$27.93M
HeartBeam, Inc.
BEAT
$26.10M
Cytosorbents Corporation
CTSO
$25.11M
IceCure Medical Ltd
ICCM
$5.38M
Vicarious Surgical Inc.
RBOT
$3.30M
Inotiv, Inc.
NOTV
$2.79M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does BDMD generate?
Baird Medical Investment Holdings Limited (BDMD) reported $22.54M of revenue in fiscal 2025.
Is BDMD profitable?
Baird Medical Investment Holdings Limited (BDMD) reported -$27,278,005.00 of net income, with a net margin of -121.0%.
Explore More
Continue the stock analysis
Jump to another research area for this company.